Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immune system in suicide-gene therapy.

Literature DB >> 8988108

Immune system in suicide-gene therapy.

S M Freeman¹, R Ramesh, A J Marrogi.

Abstract

Mesh：

Substances：

Year: 1997 PMID： 8988108 DOI： 10.1016/S0140-6736(97)22001-5

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

23 in total

1. Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors: Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal: Stem Cell Res Ther Date: 2018-12-07 Impact factor: 6.832

2. Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo.

Authors: Olga Zolochevska; Xueqing Xia; B Jill Williams; Alistair Ramsay; Shulin Li; Marxa L Figueiredo
Journal: Hum Gene Ther Date: 2011-09-01 Impact factor: 5.695

3. Gene therapy of HSV-TK transferred by the EBV based expression vector on experimental hepatocellular carcinoma.

Authors: Q Ding; Z Wu; X Chen; A H Musa; J Hu; Y Zhan
Journal: J Tongji Med Univ Date: 2001

4. IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.

Authors: A Natsume; K Tsujimura; M Mizuno; T Takahashi; J Yoshida
Journal: J Neurooncol Date: 2000-04 Impact factor: 4.130

5. Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy.

Authors: Zahidul Khan; Wolfgang Knecht; Mette Willer; Elzbieta Rozpedowska; Peter Kristoffersen; Anders Ranegaard Clausen; Birgitte Munch-Petersen; Per M Almqvist; Zoran Gojkovic; Jure Piskur; Tomas J Ekström
Journal: Neuro Oncol Date: 2010-02-13 Impact factor: 12.300

10. Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo.

Authors: A Ardiani; M Sanchez-Bonilla; M E Black
Journal: Cancer Gene Ther Date: 2009-09-18 Impact factor: 5.987

Immune system in suicide-gene therapy.

1. Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

2. Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo.

3. Gene therapy of HSV-TK transferred by the EBV based expression vector on experimental hepatocellular carcinoma.

4. IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.

5. Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy.

6. TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancer.

7. Antimetastatic effect of suicide gene therapy for mouse mammary cancers requires T-cell-mediated immune responses.

8. Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector.

Review 9. Recent progress in the research of suicide gene therapy for malignant glioma.

10. Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo.